会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 20. 发明授权
    • Tri-salt form of metformin
    • 三盐形式的二甲双胍
    • US08765811B2
    • 2014-07-01
    • US13841970
    • 2013-03-15
    • Thetis Pharmaceuticals LLC
    • Banavara L. MylariFrank C. Sciavolino
    • C07C279/02
    • A61K31/205C07C57/03C07C229/24C07C279/02C07C279/26
    • Provided herein are tri-salt compounds comprising a compound having two acidic functional groups and one basic functional groups (e.g., aspartate or glutamate), metformin, and polyunsaturated fatty acids, such as eicosapentaenoate or docosahexaenoate. The salts can be used in the treatment of diabetes, diabetes with concomitant dyslipidemia (e.g., high triglycerides) and diabetes exacerbated cardiovascular complications, such as cardiac arrhythmia, cardiac ischemia, myocardial infarction, cardiomyopathy, and stroke. The compounds of this invention are also useful in treating obesity.
    • 本文提供了三盐化合物,其包含具有两个酸性官能团和一个碱性官能团(例如天冬氨酸或谷氨酸盐),二甲双胍和多不饱和脂肪酸的化合物,例如二十碳五烯酸酯或二十二碳六烯酸酯。 这些盐可以用于治疗糖尿病,伴有血脂异常的糖尿病(例如高甘油三酸酯)和糖尿病加重的心血管并发症,例如心律失常,心脏缺血,心肌梗塞,心肌病和中风。 本发明的化合物也可用于治疗肥胖症。